PMID- 26740337 OWN - NLM STAT- MEDLINE DCOM- 20180123 LR - 20181113 IS - 1476-5527 (Electronic) IS - 0950-9240 (Linking) VI - 30 IP - 11 DP - 2016 Nov TI - Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal. PG - 726-730 LID - 10.1038/jhh.2015.120 [doi] AB - MicRoAlbuminuria sCreening survEy (RACE) was a multicentre, observational, cross-sectional study conducted in primary health-care settings of Portugal. Here, we present a post-hoc analysis from the RACE study, assessing the renal and cardiovascular (CV) risk predictive value of two different microalbuminuria (MA) screening methods, nephelometry with 24-h urine (MA-24 h) and Micral test with occasional urine (MicralA) in patients with hypertension (HTN) with/without type 2 diabetes mellitus (T2DM). Out of 3065 patients, 1173 (38.3%) were in the HTN group without T2DM (HTN) and 1892 (61.7%) in the HTN group with T2DM (HTN+T2DM). The overall prevalence of MA was 50.6% determined by MicralA and 22.1% with MA-24 h. Urinary albumin excretion data obtained by both techniques correlated significantly (r(s)=0.586; P<0.001). In all subjects, MicralA showed a sensitivity of 93%, specificity of 62% for detection of MA, with a positive predictive value of 41% and negative predictive value of 97%. With both methods, the presence of MA was independently associated with a higher risk (1.5- to 2.9-fold) of CV and renal organ damage in both HTN and HTN+T2DM groups. MicralA, due to its high sensitivity and negative predictive value, can be considered as a valid and reliable method for MA screening in patients with HTN with/without T2DM. FAU - Polonia, J AU - Polonia J AD - Department of Medicine, CINTESIS, Faculty of Medicine University of Porto, Hospital Pedro Hispano, Oporto, Portugal. FAU - Carvalho, D AU - Carvalho D AD - Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar de S Joao, Faculty of Medicine University of Porto, Instituto de Investigacao e Inovacao em Saude, Universidade do Porto, Porto, Portugal. FAU - Nazare, J AU - Nazare J AD - Department of Cardiology, CHLO-Hospital de Egas Moniz, Lisbon, Portugal. FAU - Martins, L AU - Martins L AD - Department of Cardiology, Hospital Santa Maria da Feira, Santa Maria da Feira, Portugal. FAU - da Silva, P M AU - da Silva PM AD - Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal. FAU - Aguiar, C AU - Aguiar C AD - Department of Cardiology, Hospital de Santa Cruz, Carnaxide, Portugal. FAU - Manso, M C AU - Manso MC AD - Faculty of Health Sciences, Universidade Fernando Pessoa, CIAGEB-UFP, REQUIMTE-Universidade do Porto, Oporto, Portugal. FAU - Carqueja, T AU - Carqueja T AD - Medical Department, Novartis Farma, Porto Salvo, Portugal. LA - eng PT - Journal Article PT - Multicenter Study PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20160107 PL - England TA - J Hum Hypertens JT - Journal of human hypertension JID - 8811625 SB - IM MH - Aged MH - Albuminuria/*diagnosis/*epidemiology MH - Area Under Curve MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/diagnosis/*epidemiology MH - Diabetic Nephropathies/*diagnosis/*epidemiology MH - Female MH - Humans MH - Hypertension/diagnosis/*epidemiology MH - Male MH - Mass Screening/*methods MH - Middle Aged MH - Nephelometry and Turbidimetry MH - Portugal/epidemiology MH - Predictive Value of Tests MH - Prevalence MH - Primary Health Care MH - ROC Curve MH - Reproducibility of Results MH - Risk Factors MH - Urinalysis EDAT- 2016/01/08 06:00 MHDA- 2018/01/24 06:00 CRDT- 2016/01/08 06:00 PHST- 2015/02/24 00:00 [received] PHST- 2015/10/22 00:00 [revised] PHST- 2015/11/03 00:00 [accepted] PHST- 2016/01/08 06:00 [pubmed] PHST- 2018/01/24 06:00 [medline] PHST- 2016/01/08 06:00 [entrez] AID - jhh2015120 [pii] AID - 10.1038/jhh.2015.120 [doi] PST - ppublish SO - J Hum Hypertens. 2016 Nov;30(11):726-730. doi: 10.1038/jhh.2015.120. Epub 2016 Jan 7.